OnKure Therapeutics, Inc. (OKUR) Financials

OKUR Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 198.7 million 14.3 million
Dec. 31, 2025 62.1 million 5.9 million
Sept. 30, 2025 72.8 million 6.4 million
June 30, 2025 86.1 million 7.9 million

OKUR Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -12.9 million 2.8 million
Dec. 31, 2025 -11.5 million 3.0 million
Sept. 30, 2025 -13.0 million 3.0 million
June 30, 2025 -13.3 million 2.9 million

OKUR Net Income

No data available :(

OKUR Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 192.1 million - -
Dec. 31, 2025 59.1 million - 549000
Sept. 30, 2025 70.3 million 120000 687000
June 30, 2025 83.4 million - 823000

OKUR Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 13.7 million
Dec. 31, 2025 13.5 million
Sept. 30, 2025 13.5 million
June 30, 2025 13.5 million

OKUR Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 5000 11.7 million 3.9 million -
Dec. 31, 2025 9000 10.7 million 3.4 million -
Sept. 30, 2025 6000 11.9 million 3.6 million -
June 30, 2025 13000 12.6 million 3.7 million -

OKUR Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 - 203000
Dec. 31, 2025 - 202000
Sept. 30, 2025 - -
June 30, 2025 - 212000

OKUR

Price: $4.48

52 week price:
1.91
5.38

Earnings Per Share: -4.32 USD

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 57.3 million

Links: